When the Supreme Court first invalidated a software patent in 1972, it specifically invited Congress to clarify whether it intended software to be patentable.
According to the suit, the USPTO has committed the same errors in calculating adjustments to the Novartis patent terms that were invalidated by the U.S. Court of Appeals for the Federal Circuit in its Jan. 7 decision in Wyeth.